Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Trial of ZOSTAVAX in Adults 50 to 59 Years of Age
2007-004020-20Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Sep 2007
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in herpes zoster (HZ) comparing ZOSTAVAX vaccine with Placebo (2 arms). Primary endpoint: Incidence of herpes zoster. Started Sep 2007; status: completed.
02
Drugs
zoster vaccine, live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on 2007-004020-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004020-20.